PIK3CA mutations in glioblastoma multiforme

被引:86
作者
Hartmann, C [1 ]
Bartels, G [1 ]
Gehlhaar, C [1 ]
Holtkamp, N [1 ]
von Deimling, A [1 ]
机构
[1] Univ Med Berlin, Charite, Dept Neuropathol, D-13353 Berlin, Germany
关键词
glioblastoma multiforme; PIK3CA; PTEN; chromosome; 10; TP53;
D O I
10.1007/s00401-005-1000-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma multiforme WHO grade IV is the most common and malignant variant of astrocytic tumors. Loss of heterozygosity of chromosome 10 and mutations in the tumor suppressor gene PTEN on 10q are molecular hallmarks of glioblastomas. Recently, mutations were identified in PIK3CA, encoding a protein that antagonizes the function of PTEN protein in the PI3K/Akt pathway. To address the question whether an exclusive mutation pattern can be observed in PIK3CA and PTEN, we determined the frequency of mutations in both genes. All coding exons were examined by single strand confirmation polymorphism and direct sequencing. Additionally, we analyzed chromosome 10 for loss of heterozygosity and evaluated the mutational status of TP53. In 70 glioblastomas, 5 (7%) PIK3CA mutations and 10 (14%) PTEN mutations were found. All mutations in PIK3CA located to exons 1, 9 and 20, thereby supporting the concept of mutational hot spot regions. In all but one glioblastoma, mutations were seen either in PIK3CA or in PTEN. In conclusion, the frequency of PIK3CA mutations in glioblastomas appears to be much lower than initially reported.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 50 条
[41]   Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review [J].
Starzynska, Anna ;
Sejda, Aleksandra ;
Adamska, Paulina ;
Marvaso, Giulia ;
Sakowicz-Burkiewicz, Monika ;
Adamski, Lukasz ;
Jereczek-Fossa, Barbara A. .
ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (01) :207-217
[42]   Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells [J].
Dunn, Sianadh ;
Lombardi, Olivia ;
Lukoszek, Radoslaw ;
Cowling, Victoria H. .
OPEN BIOLOGY, 2019, 9 (04)
[43]   Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab [J].
Cizkova, M. ;
Dujaric, M-E ;
Lehmann-Che, J. ;
Scott, V. ;
Tembo, O. ;
Asselain, B. ;
Pierga, J-Y ;
Marty, M. ;
de Cremoux, P. ;
Spyratos, F. ;
Bieche, I. .
BRITISH JOURNAL OF CANCER, 2013, 108 (09) :1807-1809
[44]   PIK3CA-mutations in breast cancer [J].
Reinhardt, Kristin ;
Stueckrath, Kathrin ;
Hartung, Carolin ;
Kaufhold, Sandy ;
Uleer, Christoph ;
Hanf, Volker ;
Lantzsch, Tillmann ;
Peschel, Susanne ;
John, Jutta ;
Poehler, Marleen ;
Bauer, Marcus ;
Buerrig, Friedrich Karl ;
Weigert, Edith ;
Buchmann, Joerg ;
Kantelhardt, Eva Johanna ;
Thomssen, Christoph ;
Vetter, Martina .
BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) :483-493
[45]   PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis [J].
Bredin, Hanna K. ;
Krakstad, Camilla ;
Hoivik, Erling A. .
PLOS ONE, 2023, 18 (03)
[46]   PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors [J].
Konopka, Bozena ;
Janiec-Jankowska, Aneta ;
Kwiatkowska, Ewa ;
Najmola, Urszula ;
Bidzinski, Maniusz ;
Olszewski, Wlodzimierz ;
Goluda, Cyprian .
HUMAN PATHOLOGY, 2011, 42 (11) :1710-1719
[47]   PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3′-kinase pathway alterations might be associated with favorable prognosis [J].
Dong, Ying ;
Yang, Xi ;
Wong, Oscar ;
Zhang, Xiaoming ;
Liang, Ying ;
Zhang, Ying ;
Wong, Wei ;
Nong, Lin ;
Liao, Qinping ;
Li, Ting .
HUMAN PATHOLOGY, 2012, 43 (08) :1197-1205
[48]   PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis [J].
Aleskandarany, Mohammed A. ;
Rakha, Emad A. ;
Ahmed, Mohamed A. H. ;
Powe, Desmond G. ;
Paish, Emma C. ;
Macmillan, R. Douglas ;
Ellis, Ian O. ;
Green, Andrew R. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (01) :45-53
[49]   The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer [J].
Cutano, Valentina ;
Chia, Ming Li ;
Wigmore, Eleanor M. ;
Hopcroft, Lorna ;
Williamson, Stuart C. ;
Christie, Amanda L. ;
Willis, Brandon ;
Kerr, James ;
Ashforth, Jenny ;
Fox, Rhys ;
D'Arcy, Sophie ;
Bradshaw, Lauren ;
Blaker, Catherine ;
Eberlein, Cath ;
Montava-Garriga, Lambert ;
de Bruin, Elza C. ;
Critchlow, Susan E. ;
Brindle, Kevin M. ;
Barry, Simon T. ;
Ros, Susana .
NPJ BREAST CANCER, 2025, 11 (01)
[50]   Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer [J].
Stec, Rafal ;
Semeniuk-Wojtas, Aleksandra ;
Charkiewicz, Radoslaw ;
Bodnar, Lubomir ;
Korniluk, Jan ;
Smoter, Marta ;
Chyczewski, Lech ;
Niklinski, Jacek ;
Szczylik, Cezary .
ONCOLOGY LETTERS, 2015, 10 (03) :1423-1429